Abstract
No public abstract is available from the verified source records.
Naijun Yuan, Manshi Tang, Kaijie She, Minyi Huang, Ruotong Feng, Qingyu Ma
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The global burden of neurological disorders: translating evidence into policy
10.1016/s1474-4422(19)30411-9 · 2020
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
10.1016/s0140-6736(21)02143-7 · 2021
Alzheimer’s disease
10.1016/s0140-6736(20)32205-4 · 2021
Diagnosis and treatment of Parkinson disease: a review
10.1001/jama.2019.22360 · 2020
Neuropsychological profile linked to low dopamine: in Alzheimer’s disease, major depression, and Parkinson’s disease
10.1136/jnnp.53.10.915 · 1990
A multi-trait association analysis of brain disorders and platelet traits identifies novel susceptibility loci for major depression, Alzheimer’s and Parkinson’s Disease
10.3390/cells12020245 · 2023
Luteolin as a modulator of skin aging and inflammation
10.1002/biof.1699 · 2021
Paving luteolin therapeutic potentialities and agro-food-pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits
10.1155/2021/1987588 · 2021
Protection against Alzheimer’s disease by luteolin: role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis
datacite
Confidence 0%
10.1002/biof.1703 · 2021
Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants
10.1021/jf000892m · 2001
Flavonols and flavones as potential anti-inflammatory, antioxidant, and antibacterial compounds
10.1155/2022/9966750 · 2022
Flavonoids and caffeoylquinic acids in Chrysanthemum morifolium Ramat flowers: a potentially rich source of bioactive compounds
10.1016/j.foodchem.2020.128733 · 2021
Luteolin, a promising quorum quencher mitigates virulence factors production in Pseudomonas aeruginosa - in vitro and in vivo approach
10.1016/j.micpath.2023.106123 · 2023
Bisphenol A-induced ovarian damage countered by luteolin: experiments in in vitro CHO cells and in vivo PCOS phenotype zebrafish
10.1016/j.tice.2024.102532 · 2024
An integrated pharmacology-based analysis for antidepressant mechanism of Chinese herbal formula Xiao-Yao-San
10.3389/fphar.2020.00284 · 2020
Luteolin ameliorates chronic stress-induced depressive-like behaviors in mice by promoting the Arginase-1+ microglial phenotype via a PPARγ-dependent mechanism
10.1038/s41401-024-01402-9 · 2025
Luteolin as an anti-inflammatory and neuroprotective agent: a brief review
10.1016/j.brainresbull.2015.09.002 · 2015
Luteolin for neurodegenerative diseases: a review
10.1007/s43440-024-00610-8 · 2024
Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF-κB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis
10.1007/s10787-025-01846-3 · 2025
Genetic evidence supporting a causal role of depression in Alzheimer's disease
10.1016/j.biopsych.2021.11.025 · 2022
Baicalein alleviates depression-like behavior in rotenone-induced Parkinson’s disease model in mice through activating the BDNF/TrkB/CREB pathway
10.1016/j.biopha.2021.111556 · 2021
Autism and depression are connected: a report of two complimentary network studies
10.1177/1362361319872373 · 2020
Polygonatum sibiricum polysaccharide prevents depression-like behaviors by reducing oxidative stress, inflammation, and cellular and synaptic damage
10.1016/j.jep.2021.114164 · 2021
Neuroinflammation in Parkinson’s disease: a target for neuroprotection?
10.1016/s1474-4422(09)70062-6 · 2009
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression
10.1038/mp.2016.144 · 2017
Role of Nrf2 in synaptic plasticity and memory in Alzheimer’s disease
10.3390/cells10081884 · 2021
Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease
10.1111/acel.13031 · 2019
Molecular pathways of major depressive disorder converge on the synapse
10.1038/s41380-022-01806-1 · 2023
The synapse as a treatment avenue for Alzheimer’s Disease
10.1038/s41380-022-01565-z · 2022
Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease
10.1016/j.tins.2018.11.001 · 2019
Skeletal and neurological risks demonstrated in zebrafish due to second-hand cigarette smoke and the neutralization of luteolin
10.1016/j.tice.2023.102259 · 2023
Luteolin photo-protects zebrafish from environmental stressor ultraviolet radiation (UVB)
10.1080/15287394.2023.2249944 · 2023
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia
10.1016/j.nbd.2022.105611 · 2022
Luteolin-7-O-glucuronide improves depression-like and stress coping behaviors in sleep deprivation stress model by activation of the BDNF signaling
10.3390/nu14163314 · 2022
Luteolin modulates neural stem cells fate determination: in vitro study on human neural stem cells, and in vivo study on LPS-induced depression mice model
10.3389/fcell.2021.753279 · 2021
Luteolin alleviates depression-like behavior by modulating glycerophospholipid metabolism in the hippocampus and prefrontal cortex of LOD rats
10.1111/cns.14455 · 2024
Noise induced depression-like behavior, neuroinflammation and synaptic plasticity impairments: the protective effects of luteolin
10.1007/s11064-022-03683-0 · 2022
Potential anxiolytic and antidepressant-like effects of luteolin in a chronic constriction injury rat model of neuropathic pain: role of oxidative stress, neurotrophins, and inflammatory factors
10.1016/j.intimp.2023.110520 · 2023
Luteolin reduces fear, anxiety, and depression in rats with post-traumatic stress disorder
10.1080/19768354.2022.2104925 · 2022
Luteolin enhances choroid plexus 5-MTHF brain transport to promote hippocampal neurogenesis in LOD rats
10.3389/fphar.2022.826568 · 2022
Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters
10.1016/j.biopha.2022.114078 · doi-reference
Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer’s disease
10.2174/1871527318666190319141835 · doi-reference
Brain targeted luteolin-graphene oxide nanoparticle abrogates polyethylene terephthalate induced altered neurological response in zebrafish
10.1007/s11033-023-08960-x · doi-reference
A novel host-guest complex based on biotin functionalized polyamine-β-cyclodextrin for tumor targeted delivery of luteolin
10.1016/j.molstruc.2021.130339 · doi-reference
Flavonoids in neurodegeneration: limitations and strategies to cross CNS barriers
10.2174/0929867323666160809094934 · doi-reference
Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders
10.3389/fnut.2026.1774416 · doi-reference
Dietary luteolin: a narrative review focusing on its pharmacokinetic properties and effects on glycolipid metabolism
10.1021/acs.jafc.0c08085 · doi-reference
Solubility of luteolin in ethanol + water mixed solvents at different temperatures
10.1021/je900381r · doi-reference
Production of luteolin/biopolymer microspheres by supercritical assisted atomization
10.1021/acs.iecr.7b00211 · doi-reference
Tau accelerates α-synuclein aggregation and spreading in Parkinson’s disease
10.1093/brain/awac171 · doi-reference
Tau pathology in Parkinson’s disease
10.3389/fneur.2018.00809 · doi-reference
Differential role of CSF α-synuclein species, tau, and Aβ42 in Parkinson’s disease
10.3389/fnagi.2014.00053 · doi-reference
Presence of tau pathology within foetal neural allografts in patients with Huntington’s and Parkinson’s disease
10.1093/brain/awx255 · doi-reference
Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington’s disease mouse striatal cells
10.1016/j.neuint.2015.10.004 · doi-reference
Luteolin in the Qi Bi Anshen decoction improves propionic acid-induced autism-like behavior in rats by inhibiting LRP1/MMP9
10.1016/j.phymed.2023.154965 · doi-reference
Active components from Lagotis brachystachya maintain uric acid homeostasis by inhibiting renal TLR4-NLRP3 signaling in hyperuricemic mice
10.1007/s10787-021-00844-5 · doi-reference
The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells
10.1111/j.1365-2567.2005.02156.x · doi-reference
Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury
10.1371/journal.pone.0311922 · doi-reference
Bioactive flavonoids and catechols as Hif1 and Nrf2 protein stabilizers - Implications for Parkinson’s disease
10.14336/ad.2016.0505 · doi-reference
Luteolin protects human ARPE-19 retinal pigment epithelium cells from blue light-induced phototoxicity through activation of Nrf2/Keap1 signaling
10.1080/10715762.2025.2503832 · doi-reference
In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-β inhibition
10.1038/s41598-023-47069-w · doi-reference
Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity
10.1089/jmf.2010.0310 · doi-reference
Luteolin inhibits ferroptosis of HUVEC by regulating the Sirt1/Nrf2 pathway
10.1007/s12013-025-01831-1 · doi-reference
Luteolin induces GPX4-dependent ferroptosis and enhances immune activation in colon cancer
10.1016/j.phymed.2025.157117 · doi-reference
Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight
10.1021/bi300531c · doi-reference
Discovery and characterization of natural product luteolin as an effective inhibitor of human pyridoxal kinase
10.1016/j.bioorg.2023.107057 · doi-reference
Mode of peroxisome proliferator-activated receptor γ activation by luteolin
10.1124/mol.111.076216 · doi-reference
On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex
10.1023/a:1009229429250 · doi-reference
Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target
10.1134/s0006297913010033 · doi-reference
Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype
10.1186/1742-2094-7-3 · doi-reference
Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant
10.1371/journal.pone.0162717 · doi-reference
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson’s disease
10.1096/fj.04-2751com · doi-reference
Synuclein activates microglia in a model of Parkinson’s disease
10.1016/j.neurobiolaging.2007.04.006 · doi-reference
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
10.1016/j.freeradbiomed.2013.01.003 · doi-reference
Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation
10.1016/j.neulet.2008.10.046 · doi-reference
Inhibition of α-synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
10.1080/15376516.2017.1339155 · doi-reference
Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells
10.1371/journal.pone.0097880 · doi-reference
Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells
10.3109/13880209.2012.716852 · doi-reference
Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice
10.1016/j.tox.2019.152256 · doi-reference
Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson's disease and inflammatory pathways
10.1080/01480545.2018.1504961 · doi-reference